Koji Nagata

ORCID: 0000-0002-4704-0603 · 2 papers in corpus

2025

Real-World Outcomes of Subcutaneous PHESGO® in HER2-Positive Breast Cancer: Pathological Response, Sequencing, and Safety

·doi:10.20944/preprints202509.0499.v1

Background: Subcutaneous pertuzumab and trastuzumab with hyaluronidase (PHESGO®) provides a convenient alternative to intravenous dual HER2 blockade, offering markedly shorter administration time. However, real-world evidence in Asian popu…

article 2015

A Case of Endometriosis of the Ileum with Metastatic Involvement of Endosalpingiosis in the Regional Lymph Node

·doi:10.3919/jjsa.76.2220

The sigmoid colon, and rectum are major sites of endometriosis development, but in contrast, small intestinal endometriosis is rare. We encountered a case of endometriosis of the ileum with endosalpingiosis in the regional lymph node treate…